Trump Held Up a Newspaper Headline Proving Biden’s Policy Worked. He Didn’t Read the Article.

There is a particular species of political theater that demands to be analyzed not as gaffe but as structure. On Friday, the president of the United States walked up to the press pool holding a print-out of a Washington Post headline, waved it like a man displaying a trout he had just pulled from a stream, and declared: “I told you that was going to happen.” The headline announced the sharpest drop in prescription drug prices in more than 60 years. The White House posted the photograph to its official accounts with the caption “POV: you bring the receipts.” Karoline Leavitt shared it. Steven Cheung, the communications director, posted a screenshot of the headline on his own account, added “All thanks to President Trump!” and, in what one might call an editorial decision, included no link to the article.

Jens Cederskjold (BY) via wikimedia

One understands why. The article, published Thursday, reports that independent experts attribute the price decline not to anything Trump has done but to a provision of the Inflation Reduction Act, signed by Joe Biden in 2022, that requires Medicare to negotiate prices for certain widely used prescription drugs. The first negotiated reductions took effect at the beginning of this year. Richard Frank, professor emeritus of health economics at Harvard, told the Post he would place his money on the IRA, not Trump’s policies. Stacie Dusetzina, a health policy professor at Vanderbilt, said the same. The Bureau of Labor Statistics recorded a 3.1 percent drop in prescription drug prices in July. The former BLS commissioner, one recalls, was fired by Trump last year for producing job numbers he called “fake.”

What we are observing is not simple hypocrisy, which would be too easy and too boring. It is something more interesting and more durable: an administration whose relationship to policy outcomes is purely appropriative. The machinery of the Inflation Reduction Act, a sprawling $1.6 trillion legislative package, was designed to be difficult to dismantle, and it has been. A POLITICO analysis published the same day found that of nearly $1 trillion in direct federal spending authorized by Biden’s climate and infrastructure laws, Trump has managed to cut only about 6 percent. Roughly $600 billion remains available. He has had more success wiping out tax credits, eliminating more than $540 billion in incentives for electric vehicles, wind, and solar. Automakers have canceled EV factory plans. Power companies have traded wind projects for natural gas plants, in some cases after the administration agreed to pay them a billion dollars or more to switch.

https://kaboompics.com/ / Pexels

But the drug pricing provision is different. It is not a grant to be frozen or a tax credit to be repealed. It is a statutory requirement embedded in Medicare’s purchasing architecture. The negotiations happened. The prices came down. The mechanism is already operating. You cannot hold up a headline and wish away the causal chain that produced it, though you can certainly try.

The deeper pattern here is worth naming because it recurs across this administration’s conduct. Trump’s White House has spent 18 months denouncing the Inflation Reduction Act as a “Green New Scam,” dismantling its clean energy provisions with considerable enthusiasm, and firing the statisticians whose data might prove inconvenient. Yet when that same legislative architecture produces a measurable benefit that happens to land during his term, the communications office treats it as a receipt. The policy is loathed. The outcome is claimed. The article is not linked.

Jennifer Granholm (Public domain) via Wikimedia Commons

This is not a contradiction. It is a methodology. You dismantle the structure, take credit for the output, and bank on the assumption that no one will read past the headline. The president, in this instance, did not even read past his own hand.